Alternatives to MeMed

Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.

Hacking healthcare with CRISPR technology.

Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

EarliPoint Health develops a digital health platform for earlier identification and treatment of autism spectrum disorder (ASD) in children.

PixCell Medical develops and commercializes point-of-care blood diagnostic solutions for rapid and accurate results.

ImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Developing CORA, a smart exam for early detection of coronary artery disease.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

MedHub-AI develops an AI-based decision support system for interventional cardiologists to enable precision cardiac care.

AI-powered diagnostic platform detecting and interpreting inaccessible body infra-sounds for enhanced medical diagnosis.

Developing novel diagnostics to predict patient response to immunotherapy.

AI-powered blood analysis for precise substance tracing and classification in healthcare and research.

Develops in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing.

AI-powered blood test for early cancer detection and subtyping.

AI-driven diagnostics that convert medical images into actionable genomic insights for faster cancer treatment decisions.

Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.

Pioneering volatile markers (VM) tests for early cancer detection in large-scale populations.

Clinical reasoning AI engine for scalable, high-value healthcare intake and assessment.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Harnessing genetic data for digital insights in rare and germline disorders.

Develops toilet-integrated diagnostic technology for early health condition detection.

Developing advanced diagnostic technology to expand global access to healthcare.

AI-driven platform for faster and more efficient diagnosis of women's health issues.

AI-powered breath diagnostics for sleep apnea, allergies, and asthma.

AI-powered respiratory diagnosis for faster and more accessible lung disease testing.

Provides AI-powered data analysis solutions for molecular diagnostics and research, streamlining qPCR data interpretation.

Portable, affordable, AI-powered hematology lab for instant blood test results.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered spatial biology platform for precision medicine and drug development.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Digital physical therapy and recovery platform using everyday sensors for ongoing health diagnostics.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Digital leader in preventive heart health using connected devices and AI coaching.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Transforms smartphone cameras into medical devices for home urinalysis and digitized wound care.

Bioinformatics platform for rapid discovery and validation of precision mental health treatments.

Personalized nutrition and metabolic health platform using gut microbiome and AI.

Pentaomix develops a breakthrough biopsy imaging modality for unprecedented accuracy in pathology analysis.

Personalized diagnostics for cancer genomic markers at the point of treatment.

AI-powered real-time guidance and quality assessment for cardiac ultrasound imaging.

Develops multi-spectral imaging solutions for autonomous ophthalmic screening and diagnostics.

Bioelectric medicine company advancing neurorecovery for stroke and neurological conditions.

AI-powered platform for autonomous, point-of-care interpretation of fundus images for diabetic retinopathy.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Develops technology for early detection and tracking of diseases like Alzheimer's and AMD through non-invasive eye exams.

Developing advanced magnetic resonance imaging (MRI) technology for enhanced medical diagnostics.

Global network of clinics using AI and data science to treat age-related cognitive and functional decline.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

MDacne is a mobile app that uses AI-powered computer vision for real-time acne analysis and provides personalized treatment.

AI-powered vocal biomarkers for health screening, detection, monitoring, and prediction.

AI and eye-tracking platform for early detection and treatment of pediatric vision loss.

AI-powered diagnostic solutions for veterinary clinics, including the Vetscan Imagyst analyzer.